(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Trial details
- Registry ID
- NCT04996875
- Phase
- Phase 2
The PDUFA goal date for bezuclastinib (CGT9486) in GIST is 30 Nov 2026, as disclosed by Cogent Biosciences, Inc. (COGT).
Drug identity checked against registry records
Also recorded as CGT9486; PLX9486
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisNCT04996875 | COGT | Phase 2 | Recruiting | 2025-09-19Actual |
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2026-11-30Day | bezuclastinibCogent Biosciences, Inc. · COGT | Company-disclosed PDUFA goal dateAnnounced review target | GIST | Open original sourceRead source excerptPreparing for anticipated bezuclastinib launch in GIST; PDUFA action date November 30, 2026 First seen: 07 Nov 2026 · Evidence last checked: 07 Nov 2026 |
| 2026-12-30Day | bezuclastinibCogent Biosciences, Inc. · COGT | Company-disclosed PDUFA goal dateAnnounced review target | NonAdvSM | Open original sourceRead source excerptWe submitted the first NDA for bezuclastinib in patients with NonAdvSM in December 2025, which was accepted by the FDA in March 2026. The FDA assigned a Prescription Drug User Fee Act ("PDUFA") target action date of December 30, 2026. First seen: 07 Nov 2026 · Evidence last checked: 07 Nov 2026 |
| 2026-12-30Day | bezuclastinibCogent Biosciences, Inc. · COGT | Company-disclosed PDUFA goal dateAnnounced review target | NonAdvSM | Open original sourceRead source excerptPotential FDA approval of bezuclastinib in NonAdvSM – PDUFA date of December 30, 2026 First seen: 08 Nov 2026 · Evidence last checked: 08 Nov 2026 |
| 2027-06-29Day | bezuclastinibCogent Biosciences, Inc. · COGT | Company-disclosed PDUFA goal dateAnnounced review target | AdvSM | Open original sourceRead source excerptPotential FDA approval of bezuclastinib in AdvSM – PDUFA date of June 29, 2027 First seen: 08 Nov 2026 · Evidence last checked: 08 Nov 2026 |